Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The launch of a new patient engagement group for those with blood conditions brought together patients, clinicians and researchers to discuss patient involvement.

A screening of the film People are Messy and a group discussion at the Ultimate Picture Palace marked the launch of the Oxford Blood Group, a new local patient engagement group for those with blood disorders.

People are Messy is the recording of the play by the same name produced by Oxford patients and researchers in collaboration with the Theatre of Debate. The play explores the experience of two young men with a rare inherited anaemia, and their efforts to contribute to clinical research. The play touches on the interests and constraints of all players in patient involvement, from how patients interact with their clinicians (ranging from grateful to questioning) to the time constraints on researchers and their own emotional baggage.

 

 

Photo23052018182402.jpgThe screening was followed by a group discussion moderated by Nigel Townsend, Director of Theatre of Debate. “People are Messy was a provocative and emotional film that stimulated an interesting discussion between patients, researchers and doctors,”  said Dr Bethan Psaila, a researcher at the MRC Molecular Haematology Unit (MRC MHU) who attended the event. “It underlined the importance of an open dialogue between clinician scientists and patients on priorities for medical research, and prompted a number of ideas for how the Oxford Blood Group can help us achieve that here in Oxford.” The discussion explored the different views of the audience, and considered difficult questions such as the need for psychological support for patients following a life-changing diagnosis, time constraints on NHS professionals and the lack of ‘protected time’ for researchers to involve patients in their research.

This event was a wonderful start to a great conversation. Patients, doctors and scientists, all on an equal footing, sharing viewpoints and listening to each other

“This event was a wonderful start to a great conversation. Patients, doctors and scientists, all on an equal footing, sharing viewpoints and listening to each other” said Dr Noémi Roy, Consultant Haematologist and co-founder of the Oxford Blood Group. “Only by understanding each other will we begin to make a real change in how patients are involved in shaping the research we do. So let’s keep talking. “

The Oxford Blood Group is a patient engagement group for anyone who has experience of a haematology (blood) condition, either now or in the past, as a patient or someone close to a patient. The Oxford Blood Group aims to promote and facilitate good research practice in patient and public involvement in haematology research and practice, and is supported by the Oxford Biomedical Research Centre. The launch of the Oxford Blood Group was supported by the MRC MHU.

You can find out more about the Oxford Blood Group on the video below:

 

Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.

Immune cells imperfect at distinguishing friend from foe

When it comes to distinguishing a healthy cell from an infected one that needs to be destroyed, the immune system’s killer T cells sometimes make mistakes. This discovery, described today in the journal eLife, upends a long-held belief among scientists that T cells were nearly perfect at discriminating friend from foe. The results may point to new ways to treat autoimmune diseases that cause the immune system to attack the body, or lead to improvements in cutting-edge cancer treatments.

Professor Graham Ogg elected Academy of Medical Sciences Fellow

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.